Drugs and FDA
Trump administration backs down from plan to ban kratom
Health officials will allow some levels of a powerful substance to remain in products marketed as natural, The New York Times reported.
The Trump administration is backing away from a plan to ban kratom, according to a MedPage Today roundup citing The New York Times. The Times reported that health officials will allow some levels of a powerful substance to remain in products marketed as natural. The reports do not state the levels or identify the substance in those products.
The Times linked the change to lobbying by the kratom industry and said it could help a G.O.P. donor facing wrongful death lawsuits. MedPage’s roundup also reported that the administration was backing down from its plan, but gave no further details. The reports do not say when the policy change will take effect or which products would be affected.
